Smartty Banner

SMARTT Y90 Programme Overview

SIRT Multidisciplinary AppRoach with TheraSphereTM Therapy

The SMARTT Y90 Programme is a unique peer-to-peer educational experience that explores how personalised neoadjuvant TheraSphere Y90 Therapy is proven to bridge and downstage patients at early, intermediate, and advanced HCC to curative surgery. 

This educational experience has been developed in co-operation with multi-disciplinary specialists who will take an active role in the delivery of the curriculum. 

Engage in a dynamic forum with renown transplant surgeons and other liver cancer specialists on the importance of multidisciplinary collaboration in HCC treatment strategies. Interested in future SMARTT Y90 programme opportunities?

Sign up now

Programme Overview

Steering Committee

Transplant-surgeon

2023 Curriculum

Icon_Number_One

Advances in Locoregional Neoadjuvant Therapy for HCC. Changing the Landscape in Patient Management

  • Impact of TheraSphere Y90 therapy on liver function
    Dr. Maria Varela, Hepatologist
  • TheraSphere Y90 therapy for downstaging: from right to left of BCLC
    Dr. Sherrie Bhoori, Hepatologist
  • Role of downstaging in the expanding field of transplant oncology
    Prof. Deniz Balci, HPB & Transplant Surgeon
Icon_Number_Two

Real-world case discussion from multidisciplinary team (MDT) perspective


Faculty: Prof. Arndt Vogel (Medical Oncologist and moderator), Prof. Deniz Balci (HPB & Transplant Surgeon), Dr. Irene Bargellini (Interventional Radiologist)
  • Radiation segmentectomy as an alternative to classical curative therapies
    Dr. Maria Varela, Hepatologist
  • Combining locoregional approaches with systemic treatments for HCC downstaging
    Dr. Sherrie Bhoori, Hepatologist
Icon_hospital

Ask the Experts

A unique opportunity for a dedicated virtual meeting between your centre’s MDT and members of our Steering Committee and Faculty.

Raise specific questions and explore how personalised TheraSphere Y90 Therapy could expand curative options to improve your patient outcomes.

Register to the programme

What's Next

The 2024 Programme will feature livestream activity and face-to-face local and regional summit meetings. Our SMARTT Y90 Ask-the- Expert service will continue, offering you and your centre’s MDT the chance for a customised virtual meeting with members of the expanding SMARTT Y90 Faculty.     

Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.